Intravenous Remifentanil Patient-controlled Analgesia (PCA) and Epidural Patient Controlled Epidural Analgesia (PCEA) for Labor Analgesia
NCT ID: NCT00801047
Last Updated: 2015-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
50 participants
INTERVENTIONAL
2010-02-28
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study Aim: To determine whether remifentanil is effective for labor analgesia when compared with standard treatment (epidural analgesia).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dilute Versus Concentrated Epidural Bupivacaine in Labor
NCT00197327
Patient-controlled Intravenous Analgesia With Remifentanil Infusion for Labour
NCT01563939
A Comparison Study of Patient Controlled Epidural Analgesia (PCEA) With and Without Basal Infusion Using Ropivacaine 0,15% and Fentanyl μg/ml for Pain Relief in Labor, Assessment of Efficacy and Maternal Satisfaction.
NCT02084589
Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques
NCT04814537
Programmed Intermittent Epidural Bolus Compared With Continuous Infusion in Multiparous Women
NCT06580327
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Epidural group
Bupivacaine epidural
Bupivacaine 0.1%, fentanyl 1 mic/kg
2
Remifentanil iv PCA
Remifentanil
40-50 mic per 1-2 min via PCA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine epidural
Bupivacaine 0.1%, fentanyl 1 mic/kg
Remifentanil
40-50 mic per 1-2 min via PCA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists physical status class I or II
* Body weight less than 110 kg
* In active labor (including induced labor and premature rupture of membranes)
* Cervical dilatation at 2-6 cm
* Regular contractions
* Age between 18 and 40 years old
* Gestational age greater than 36 completed weeks
* Singleton pregnancy and vertex presentation
Exclusion Criteria
* Narcotic administration in the previous 2 hours
* Previous uterine surgery
* Pre-eclampsia and the inability to adequately understand the consent form
* Blocked nose, and any indication patient for whom epidural analgesia is medically indicated (cardiac disease, suspected difficult airway)
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hadassah Medical Organization
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hadassah Medical Organization
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carolyn F Weiniger, MB ChB
Role: PRINCIPAL_INVESTIGATOR
Hadassah HMO
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hadassah Medical Organization
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hill D. Remifentanil patient-controlled analgesia should be routinely available for use in labour. Int J Obstet Anesth. 2008 Oct;17(4):336-9. doi: 10.1016/j.ijoa.2008.03.005. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
rem-epi-nov-2008- HMO-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.